Patents, Patients and Progress: A Conversation with Henry Hadad

IPWatchdog Unleashed

Send us a text

This week on IPWatchdog Unleashed we have an interesting and entertaining conversation between Gene Quinn, President & CEO of IPWatchdog, Inc., and Henry Hadad, Chief IP Counsel and Deputy General Counsel at Bristol Myers Squibb. The conversation is wide ranging. They discuss the complexities and challenges patent laws are creating for medical diagnostics and cancer treatment. Henry shares his journey from law school to becoming a key player in the biopharmaceutical industry and elaborates on groundbreaking innovations in immuno-oncology that have transformed cancer treatment. The conversation delves into the impact of legislative and judicial changes on the IP landscape, the critical role of diagnostics in healthcare, and the importance of incentivizing innovation through a robust patent system. The episode concludes with reflections on the human impact of scientific advancements and the ongoing efforts required to find a cure for cancer. Henry’s final comment is one of optimism for innovators and the patent industry.

Visit us online at IPWatchdog.com.
You can also visit our channels at YouTube, LinkedIn, X, Instagram and Facebook.